Company: AEMD
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001683168-25-008271
Chunk: 103

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 5
Chunk 103
---
Rule 10b5-1 Trading Plans 

During the three months ended September 30, 2025,
none of our directors or officers entered into, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule
10b5-1 trading arrangement,” that were intended to satisfy the affirmative defense conditions of Rule 10b5-1, in each case as defined
in Item 408 of Regulation S-K.

 25 

ITEM 6. EXHIBITS.

(a) Exhibits. The following documents are filed
as part of this report:

    Incorporated
    by Reference
  
    Exhibit
Number
     
    Exhibit Description
     
    Form
     
    SEC File No.
     
    Exhibit
Number
     
    Date
     
    Filed
Herewith

    3.1
     
    Articles of Incorporation, as amended.
     
    8-K
     
    001-37487
     
    3.1
     
    September 19, 2022

    3.2
     
    Amended and Restated Bylaws of the Company.
     
    8-K
     
    001-37487
     
    3.1
     
    September 12, 2019

    3.3
     
    Certificate of Change pursuant to NRS 78.209
     
    8-K
     
    001-37487
     
    3.1
     
    October 16, 2025

    4.1
     
    Form of Common Stock Certificate.
     
    S-1
     
    333-201334
     
    4.1
     
    December 31, 2014

    4.2
     
    Form of Warrant to Purchase Common Stock.
     
    S-1/A
     
    333-234712
     
    4.14
     
    December 11, 2019

    4.3 
     
    Form of Underwriter Warrant.
     
    S-1/A
     
    333-234712
     
    4.15
     
    December 11, 2019

    4.4
     
    Form of Common Stock Purchase Warrant.